Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Anderson

Showing results (211-220 of 235) with videos related to

Pageof 24
Sort By:
F1000Research|May 10, 2019
An in vitro model for studying CNS white matter: functional properties and experimental approachesSilvia Bijland, Gemma Thomson, Matthew Euston, et al.
Frontiers in Molecular Biosciences|October 10, 2022
The role of extracellular vesicle miRNAs and tRNAs in synovial fibroblast senescenceSusanne N Wijesinghe, James Anderson, Thomas J Brown, et al.
Pediatric Blood & Cancer|May 27, 2017
45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology GroupRalph P Ermoian, John Breneman, David O Walterhouse, et al.
Movement Ecology|March 4, 2026
A rare tropical storm event drives partial nursery evacuation by juvenile white sharks, followed by rapid aggregation reformationJack T Elstner, Emily Spurgeon, Patrick Rex, et al.
Journal of Pharmacy Practice|August 30, 2017
Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple SclerosisChristine Bell, James Anderson, Tanmoy Ganguly, et al.
The European Respiratory Journal|April 29, 2020
Pulmonary arterial hypertension with below threshold pulmonary vascular resistanceSeshika Ratwatte, James Anderson, Geoffrey Strange, et al.
Heart, Lung & Circulation|April 14, 2020
Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and ChallengesJames Anderson, Melanie Lavender, Edmund Lau, et al.
Chest|November 11, 2023
Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension TherapyKatherine Kearney, Karen Brown, David S Celermajer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2023
Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced MelanomaCaroline Robert, Matteo S Carlino, Catriona McNeil, et al.
Stroke|March 4, 2006
Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric strokeMax Wintermark, Adam E Flanders, Birgitta Velthuis, et al.
Pageof 24

Showing results (211-220 of 235) with videos related to

Sort By:
Pageof 24
F1000Research|May 10, 2019
An in vitro model for studying CNS white matter: functional properties and experimental approachesSilvia Bijland, Gemma Thomson, Matthew Euston, et al.
Frontiers in Molecular Biosciences|October 10, 2022
The role of extracellular vesicle miRNAs and tRNAs in synovial fibroblast senescenceSusanne N Wijesinghe, James Anderson, Thomas J Brown, et al.
Pediatric Blood & Cancer|May 27, 2017
45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology GroupRalph P Ermoian, John Breneman, David O Walterhouse, et al.
Movement Ecology|March 4, 2026
A rare tropical storm event drives partial nursery evacuation by juvenile white sharks, followed by rapid aggregation reformationJack T Elstner, Emily Spurgeon, Patrick Rex, et al.
Journal of Pharmacy Practice|August 30, 2017
Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple SclerosisChristine Bell, James Anderson, Tanmoy Ganguly, et al.
The European Respiratory Journal|April 29, 2020
Pulmonary arterial hypertension with below threshold pulmonary vascular resistanceSeshika Ratwatte, James Anderson, Geoffrey Strange, et al.
Heart, Lung & Circulation|April 14, 2020
Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and ChallengesJames Anderson, Melanie Lavender, Edmund Lau, et al.
Chest|November 11, 2023
Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension TherapyKatherine Kearney, Karen Brown, David S Celermajer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2023
Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced MelanomaCaroline Robert, Matteo S Carlino, Catriona McNeil, et al.
Stroke|March 4, 2006
Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric strokeMax Wintermark, Adam E Flanders, Birgitta Velthuis, et al.
Pageof 24